开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2117061, encodeId=06c3211e06105, content=审稿速度:2.0 偏重的研究方向：天然药物 经验分享：请问一下返修后在哪里提交哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Wed Mar 01 15:22:18 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150631, encodeId=5584215063130, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药理;中药复方 经验分享：SUBMISSION 01 November 2022 Submission Created 01 November 2022 Submission Incomplete 01 November 2022 Manuscript Submitted 01 November 2022 With Journal Administrator 04 November 2022 Submission Returned to Author 05 November 2022 Submission Incomplete 05 November 2022 Manuscript Resubmitted 05 November 2022 With Journal Administrator 20 January 2023 Submission Returned to Author 20 January 2023 Submission Incomplete 20 January 2023 Manuscript Resubmitted 20 January 2023 With Journal Administrator PEER REVIEW 23 November 2022 With Editor 25 December 2022 Out for Review 25 December 2022 Decision Pending 28 December 2022 Revision Required 19 January 2023 Revision Incomplete 19 January 2023 Revised Manuscript Submitted 19 January 2023 With Journal Administrator 21 January 2023 With Editor 22 January 2023 Out for Review 15 February 2023 Decision Pending 12 March 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230731/c6b65f8745254477ac28d88840cb1e0b/9e4ae2e7f9134a7c8800922fb7c19658.jpg, createdBy=94878313457, createdName=ms6000001066593523, createdTime=Mon Jul 31 16:20:12 CST 2023, time=2023-07-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190023, encodeId=aa25219002323, content=为什么已经外审了，系统还显示with editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Thu Feb 29 09:07:40 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151650, encodeId=da76215165068, content=1月投稿，3月审稿意见返回小修，4月审稿人二审完成。6月两次编辑修改，甚至索要了动物伦理批件，8月编辑无理由拒稿。。。历时7月一场空，甚至提一些无理要求，这个杂志耍人玩呢？奉劝大家慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a55438295, createdName=ms7000001567467619, createdTime=Mon Aug 07 17:20:23 CST 2023, time=2023-08-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京)]

2023-03-01 ms8000002023702013

审稿速度:2.0
偏重的研究方向：天然药物
经验分享：请问一下返修后在哪里提交哇

101 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117061, encodeId=06c3211e06105, content=审稿速度:2.0 偏重的研究方向：天然药物 经验分享：请问一下返修后在哪里提交哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Wed Mar 01 15:22:18 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150631, encodeId=5584215063130, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药理;中药复方 经验分享：SUBMISSION 01 November 2022 Submission Created 01 November 2022 Submission Incomplete 01 November 2022 Manuscript Submitted 01 November 2022 With Journal Administrator 04 November 2022 Submission Returned to Author 05 November 2022 Submission Incomplete 05 November 2022 Manuscript Resubmitted 05 November 2022 With Journal Administrator 20 January 2023 Submission Returned to Author 20 January 2023 Submission Incomplete 20 January 2023 Manuscript Resubmitted 20 January 2023 With Journal Administrator PEER REVIEW 23 November 2022 With Editor 25 December 2022 Out for Review 25 December 2022 Decision Pending 28 December 2022 Revision Required 19 January 2023 Revision Incomplete 19 January 2023 Revised Manuscript Submitted 19 January 2023 With Journal Administrator 21 January 2023 With Editor 22 January 2023 Out for Review 15 February 2023 Decision Pending 12 March 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230731/c6b65f8745254477ac28d88840cb1e0b/9e4ae2e7f9134a7c8800922fb7c19658.jpg, createdBy=94878313457, createdName=ms6000001066593523, createdTime=Mon Jul 31 16:20:12 CST 2023, time=2023-07-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190023, encodeId=aa25219002323, content=为什么已经外审了，系统还显示with editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Thu Feb 29 09:07:40 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151650, encodeId=da76215165068, content=1月投稿，3月审稿意见返回小修，4月审稿人二审完成。6月两次编辑修改，甚至索要了动物伦理批件，8月编辑无理由拒稿。。。历时7月一场空，甚至提一些无理要求，这个杂志耍人玩呢？奉劝大家慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a55438295, createdName=ms7000001567467619, createdTime=Mon Aug 07 17:20:23 CST 2023, time=2023-08-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京)]

2023-07-31 ms6000001066593523 来自广东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：药理;中药复方
经验分享：SUBMISSION
01 November 2022
Submission Created
01 November 2022
Submission Incomplete
01 November 2022
Manuscript Submitted
01 November 2022
With Journal Administrator
04 November 2022
Submission Returned to Author
05 November 2022
Submission Incomplete
05 November 2022
Manuscript Resubmitted
05 November 2022
With Journal Administrator
20 January 2023
Submission Returned to Author
20 January 2023
Submission Incomplete
20 January 2023
Manuscript Resubmitted
20 January 2023
With Journal Administrator
PEER REVIEW
23 November 2022
With Editor
25 December 2022
Out for Review
25 December 2022
Decision Pending
28 December 2022
Revision Required
19 January 2023
Revision Incomplete
19 January 2023
Revised Manuscript Submitted
19 January 2023
With Journal Administrator
21 January 2023
With Editor
22 January 2023
Out for Review
15 February 2023
Decision Pending
12 March 2023
Accepted

1 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117061, encodeId=06c3211e06105, content=审稿速度:2.0 偏重的研究方向：天然药物 经验分享：请问一下返修后在哪里提交哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Wed Mar 01 15:22:18 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150631, encodeId=5584215063130, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药理;中药复方 经验分享：SUBMISSION 01 November 2022 Submission Created 01 November 2022 Submission Incomplete 01 November 2022 Manuscript Submitted 01 November 2022 With Journal Administrator 04 November 2022 Submission Returned to Author 05 November 2022 Submission Incomplete 05 November 2022 Manuscript Resubmitted 05 November 2022 With Journal Administrator 20 January 2023 Submission Returned to Author 20 January 2023 Submission Incomplete 20 January 2023 Manuscript Resubmitted 20 January 2023 With Journal Administrator PEER REVIEW 23 November 2022 With Editor 25 December 2022 Out for Review 25 December 2022 Decision Pending 28 December 2022 Revision Required 19 January 2023 Revision Incomplete 19 January 2023 Revised Manuscript Submitted 19 January 2023 With Journal Administrator 21 January 2023 With Editor 22 January 2023 Out for Review 15 February 2023 Decision Pending 12 March 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230731/c6b65f8745254477ac28d88840cb1e0b/9e4ae2e7f9134a7c8800922fb7c19658.jpg, createdBy=94878313457, createdName=ms6000001066593523, createdTime=Mon Jul 31 16:20:12 CST 2023, time=2023-07-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190023, encodeId=aa25219002323, content=为什么已经外审了，系统还显示with editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Thu Feb 29 09:07:40 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151650, encodeId=da76215165068, content=1月投稿，3月审稿意见返回小修，4月审稿人二审完成。6月两次编辑修改，甚至索要了动物伦理批件，8月编辑无理由拒稿。。。历时7月一场空，甚至提一些无理要求，这个杂志耍人玩呢？奉劝大家慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a55438295, createdName=ms7000001567467619, createdTime=Mon Aug 07 17:20:23 CST 2023, time=2023-08-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京)]

2023-06-05 hongzhongshi 来自福建省

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：中药提取物
经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了

98 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117061, encodeId=06c3211e06105, content=审稿速度:2.0 偏重的研究方向：天然药物 经验分享：请问一下返修后在哪里提交哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Wed Mar 01 15:22:18 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150631, encodeId=5584215063130, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药理;中药复方 经验分享：SUBMISSION 01 November 2022 Submission Created 01 November 2022 Submission Incomplete 01 November 2022 Manuscript Submitted 01 November 2022 With Journal Administrator 04 November 2022 Submission Returned to Author 05 November 2022 Submission Incomplete 05 November 2022 Manuscript Resubmitted 05 November 2022 With Journal Administrator 20 January 2023 Submission Returned to Author 20 January 2023 Submission Incomplete 20 January 2023 Manuscript Resubmitted 20 January 2023 With Journal Administrator PEER REVIEW 23 November 2022 With Editor 25 December 2022 Out for Review 25 December 2022 Decision Pending 28 December 2022 Revision Required 19 January 2023 Revision Incomplete 19 January 2023 Revised Manuscript Submitted 19 January 2023 With Journal Administrator 21 January 2023 With Editor 22 January 2023 Out for Review 15 February 2023 Decision Pending 12 March 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230731/c6b65f8745254477ac28d88840cb1e0b/9e4ae2e7f9134a7c8800922fb7c19658.jpg, createdBy=94878313457, createdName=ms6000001066593523, createdTime=Mon Jul 31 16:20:12 CST 2023, time=2023-07-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190023, encodeId=aa25219002323, content=为什么已经外审了，系统还显示with editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Thu Feb 29 09:07:40 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151650, encodeId=da76215165068, content=1月投稿，3月审稿意见返回小修，4月审稿人二审完成。6月两次编辑修改，甚至索要了动物伦理批件，8月编辑无理由拒稿。。。历时7月一场空，甚至提一些无理要求，这个杂志耍人玩呢？奉劝大家慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a55438295, createdName=ms7000001567467619, createdTime=Mon Aug 07 17:20:23 CST 2023, time=2023-08-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京)]

2023-03-20 ms5000000768384636 来自四川省

审稿速度:3.0
经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。

93 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117061, encodeId=06c3211e06105, content=审稿速度:2.0 偏重的研究方向：天然药物 经验分享：请问一下返修后在哪里提交哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Wed Mar 01 15:22:18 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150631, encodeId=5584215063130, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药理;中药复方 经验分享：SUBMISSION 01 November 2022 Submission Created 01 November 2022 Submission Incomplete 01 November 2022 Manuscript Submitted 01 November 2022 With Journal Administrator 04 November 2022 Submission Returned to Author 05 November 2022 Submission Incomplete 05 November 2022 Manuscript Resubmitted 05 November 2022 With Journal Administrator 20 January 2023 Submission Returned to Author 20 January 2023 Submission Incomplete 20 January 2023 Manuscript Resubmitted 20 January 2023 With Journal Administrator PEER REVIEW 23 November 2022 With Editor 25 December 2022 Out for Review 25 December 2022 Decision Pending 28 December 2022 Revision Required 19 January 2023 Revision Incomplete 19 January 2023 Revised Manuscript Submitted 19 January 2023 With Journal Administrator 21 January 2023 With Editor 22 January 2023 Out for Review 15 February 2023 Decision Pending 12 March 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230731/c6b65f8745254477ac28d88840cb1e0b/9e4ae2e7f9134a7c8800922fb7c19658.jpg, createdBy=94878313457, createdName=ms6000001066593523, createdTime=Mon Jul 31 16:20:12 CST 2023, time=2023-07-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190023, encodeId=aa25219002323, content=为什么已经外审了，系统还显示with editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Thu Feb 29 09:07:40 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151650, encodeId=da76215165068, content=1月投稿，3月审稿意见返回小修，4月审稿人二审完成。6月两次编辑修改，甚至索要了动物伦理批件，8月编辑无理由拒稿。。。历时7月一场空，甚至提一些无理要求，这个杂志耍人玩呢？奉劝大家慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a55438295, createdName=ms7000001567467619, createdTime=Mon Aug 07 17:20:23 CST 2023, time=2023-08-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京)]

2024-02-29 ms7000001909487480 来自北京

为什么已经外审了，系统还显示with editor呢？

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117061, encodeId=06c3211e06105, content=审稿速度:2.0 偏重的研究方向：天然药物 经验分享：请问一下返修后在哪里提交哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Wed Mar 01 15:22:18 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150631, encodeId=5584215063130, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药理;中药复方 经验分享：SUBMISSION 01 November 2022 Submission Created 01 November 2022 Submission Incomplete 01 November 2022 Manuscript Submitted 01 November 2022 With Journal Administrator 04 November 2022 Submission Returned to Author 05 November 2022 Submission Incomplete 05 November 2022 Manuscript Resubmitted 05 November 2022 With Journal Administrator 20 January 2023 Submission Returned to Author 20 January 2023 Submission Incomplete 20 January 2023 Manuscript Resubmitted 20 January 2023 With Journal Administrator PEER REVIEW 23 November 2022 With Editor 25 December 2022 Out for Review 25 December 2022 Decision Pending 28 December 2022 Revision Required 19 January 2023 Revision Incomplete 19 January 2023 Revised Manuscript Submitted 19 January 2023 With Journal Administrator 21 January 2023 With Editor 22 January 2023 Out for Review 15 February 2023 Decision Pending 12 March 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230731/c6b65f8745254477ac28d88840cb1e0b/9e4ae2e7f9134a7c8800922fb7c19658.jpg, createdBy=94878313457, createdName=ms6000001066593523, createdTime=Mon Jul 31 16:20:12 CST 2023, time=2023-07-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190023, encodeId=aa25219002323, content=为什么已经外审了，系统还显示with editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Thu Feb 29 09:07:40 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151650, encodeId=da76215165068, content=1月投稿，3月审稿意见返回小修，4月审稿人二审完成。6月两次编辑修改，甚至索要了动物伦理批件，8月编辑无理由拒稿。。。历时7月一场空，甚至提一些无理要求，这个杂志耍人玩呢？奉劝大家慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a55438295, createdName=ms7000001567467619, createdTime=Mon Aug 07 17:20:23 CST 2023, time=2023-08-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京)]

2023-08-07 ms7000001567467619 来自江苏省

1月投稿，3月审稿意见返回小修，4月审稿人二审完成。6月两次编辑修改，甚至索要了动物伦理批件，8月编辑无理由拒稿。。。历时7月一场空，甚至提一些无理要求，这个杂志耍人玩呢？奉劝大家慎投

109 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117061, encodeId=06c3211e06105, content=审稿速度:2.0 偏重的研究方向：天然药物 经验分享：请问一下返修后在哪里提交哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Wed Mar 01 15:22:18 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150631, encodeId=5584215063130, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药理;中药复方 经验分享：SUBMISSION 01 November 2022 Submission Created 01 November 2022 Submission Incomplete 01 November 2022 Manuscript Submitted 01 November 2022 With Journal Administrator 04 November 2022 Submission Returned to Author 05 November 2022 Submission Incomplete 05 November 2022 Manuscript Resubmitted 05 November 2022 With Journal Administrator 20 January 2023 Submission Returned to Author 20 January 2023 Submission Incomplete 20 January 2023 Manuscript Resubmitted 20 January 2023 With Journal Administrator PEER REVIEW 23 November 2022 With Editor 25 December 2022 Out for Review 25 December 2022 Decision Pending 28 December 2022 Revision Required 19 January 2023 Revision Incomplete 19 January 2023 Revised Manuscript Submitted 19 January 2023 With Journal Administrator 21 January 2023 With Editor 22 January 2023 Out for Review 15 February 2023 Decision Pending 12 March 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230731/c6b65f8745254477ac28d88840cb1e0b/9e4ae2e7f9134a7c8800922fb7c19658.jpg, createdBy=94878313457, createdName=ms6000001066593523, createdTime=Mon Jul 31 16:20:12 CST 2023, time=2023-07-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190023, encodeId=aa25219002323, content=为什么已经外审了，系统还显示with editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Thu Feb 29 09:07:40 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151650, encodeId=da76215165068, content=1月投稿，3月审稿意见返回小修，4月审稿人二审完成。6月两次编辑修改，甚至索要了动物伦理批件，8月编辑无理由拒稿。。。历时7月一场空，甚至提一些无理要求，这个杂志耍人玩呢？奉劝大家慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a55438295, createdName=ms7000001567467619, createdTime=Mon Aug 07 17:20:23 CST 2023, time=2023-08-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京)]

2024-04-15 ms1000002137683196 来自湖南省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：成分鉴定;中药复方
经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了

95 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117061, encodeId=06c3211e06105, content=审稿速度:2.0 偏重的研究方向：天然药物 经验分享：请问一下返修后在哪里提交哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Wed Mar 01 15:22:18 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150631, encodeId=5584215063130, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药理;中药复方 经验分享：SUBMISSION 01 November 2022 Submission Created 01 November 2022 Submission Incomplete 01 November 2022 Manuscript Submitted 01 November 2022 With Journal Administrator 04 November 2022 Submission Returned to Author 05 November 2022 Submission Incomplete 05 November 2022 Manuscript Resubmitted 05 November 2022 With Journal Administrator 20 January 2023 Submission Returned to Author 20 January 2023 Submission Incomplete 20 January 2023 Manuscript Resubmitted 20 January 2023 With Journal Administrator PEER REVIEW 23 November 2022 With Editor 25 December 2022 Out for Review 25 December 2022 Decision Pending 28 December 2022 Revision Required 19 January 2023 Revision Incomplete 19 January 2023 Revised Manuscript Submitted 19 January 2023 With Journal Administrator 21 January 2023 With Editor 22 January 2023 Out for Review 15 February 2023 Decision Pending 12 March 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230731/c6b65f8745254477ac28d88840cb1e0b/9e4ae2e7f9134a7c8800922fb7c19658.jpg, createdBy=94878313457, createdName=ms6000001066593523, createdTime=Mon Jul 31 16:20:12 CST 2023, time=2023-07-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190023, encodeId=aa25219002323, content=为什么已经外审了，系统还显示with editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Thu Feb 29 09:07:40 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151650, encodeId=da76215165068, content=1月投稿，3月审稿意见返回小修，4月审稿人二审完成。6月两次编辑修改，甚至索要了动物伦理批件，8月编辑无理由拒稿。。。历时7月一场空，甚至提一些无理要求，这个杂志耍人玩呢？奉劝大家慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a55438295, createdName=ms7000001567467619, createdTime=Mon Aug 07 17:20:23 CST 2023, time=2023-08-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京)]

2019-11-25 ms3214948925389860

感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！

197 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117061, encodeId=06c3211e06105, content=审稿速度:2.0 偏重的研究方向：天然药物 经验分享：请问一下返修后在哪里提交哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Wed Mar 01 15:22:18 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150631, encodeId=5584215063130, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药理;中药复方 经验分享：SUBMISSION 01 November 2022 Submission Created 01 November 2022 Submission Incomplete 01 November 2022 Manuscript Submitted 01 November 2022 With Journal Administrator 04 November 2022 Submission Returned to Author 05 November 2022 Submission Incomplete 05 November 2022 Manuscript Resubmitted 05 November 2022 With Journal Administrator 20 January 2023 Submission Returned to Author 20 January 2023 Submission Incomplete 20 January 2023 Manuscript Resubmitted 20 January 2023 With Journal Administrator PEER REVIEW 23 November 2022 With Editor 25 December 2022 Out for Review 25 December 2022 Decision Pending 28 December 2022 Revision Required 19 January 2023 Revision Incomplete 19 January 2023 Revised Manuscript Submitted 19 January 2023 With Journal Administrator 21 January 2023 With Editor 22 January 2023 Out for Review 15 February 2023 Decision Pending 12 March 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230731/c6b65f8745254477ac28d88840cb1e0b/9e4ae2e7f9134a7c8800922fb7c19658.jpg, createdBy=94878313457, createdName=ms6000001066593523, createdTime=Mon Jul 31 16:20:12 CST 2023, time=2023-07-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190023, encodeId=aa25219002323, content=为什么已经外审了，系统还显示with editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Thu Feb 29 09:07:40 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151650, encodeId=da76215165068, content=1月投稿，3月审稿意见返回小修，4月审稿人二审完成。6月两次编辑修改，甚至索要了动物伦理批件，8月编辑无理由拒稿。。。历时7月一场空，甚至提一些无理要求，这个杂志耍人玩呢？奉劝大家慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a55438295, createdName=ms7000001567467619, createdTime=Mon Aug 07 17:20:23 CST 2023, time=2023-08-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京)]

2023-12-04 916603706 来自山东省

一年零一个月了。。。终于接收，历经无数次小修。

109 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2117061, encodeId=06c3211e06105, content=审稿速度:2.0 偏重的研究方向：天然药物 经验分享：请问一下返修后在哪里提交哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Wed Mar 01 15:22:18 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150631, encodeId=5584215063130, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药理;中药复方 经验分享：SUBMISSION 01 November 2022 Submission Created 01 November 2022 Submission Incomplete 01 November 2022 Manuscript Submitted 01 November 2022 With Journal Administrator 04 November 2022 Submission Returned to Author 05 November 2022 Submission Incomplete 05 November 2022 Manuscript Resubmitted 05 November 2022 With Journal Administrator 20 January 2023 Submission Returned to Author 20 January 2023 Submission Incomplete 20 January 2023 Manuscript Resubmitted 20 January 2023 With Journal Administrator PEER REVIEW 23 November 2022 With Editor 25 December 2022 Out for Review 25 December 2022 Decision Pending 28 December 2022 Revision Required 19 January 2023 Revision Incomplete 19 January 2023 Revised Manuscript Submitted 19 January 2023 With Journal Administrator 21 January 2023 With Editor 22 January 2023 Out for Review 15 February 2023 Decision Pending 12 March 2023 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230731/c6b65f8745254477ac28d88840cb1e0b/9e4ae2e7f9134a7c8800922fb7c19658.jpg, createdBy=94878313457, createdName=ms6000001066593523, createdTime=Mon Jul 31 16:20:12 CST 2023, time=2023-07-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190023, encodeId=aa25219002323, content=为什么已经外审了，系统还显示with editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Thu Feb 29 09:07:40 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2151650, encodeId=da76215165068, content=1月投稿，3月审稿意见返回小修，4月审稿人二审完成。6月两次编辑修改，甚至索要了动物伦理批件，8月编辑无理由拒稿。。。历时7月一场空，甚至提一些无理要求，这个杂志耍人玩呢？奉劝大家慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a55438295, createdName=ms7000001567467619, createdTime=Mon Aug 07 17:20:23 CST 2023, time=2023-08-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京)]

2024-03-08 ms8000001918173079 来自北京

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：药理实验;中药复方
经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！
先提前谢过心软的编辑和审稿人！
SUBMISSION
21 November 2023
Submission Created
24 November 2023
Submission Incomplete
24 November 2023
Manuscript Submitted
24 November 2023
With Journal Administrator
25 November 2023
Submission Returned to Author
01 December 2023
Submission Incomplete
01 December 2023
Manuscript Resubmitted
01 December 2023
With Journal Administrator
PEER REVIEW
09 December 2023
With Editor
11 January 2024
Out for Review
11 January 2024
Revision Required
20 January 2024
Revision Incomplete
20 January 2024
Revised Manuscript Submitted
20 January 2024
With Journal Administrator
23 January 2024
With Editor
24 January 2024
Out for Review
25 February 2024
Revision Required
28 February 2024
Revision Incomplete
28 February 2024
Revised Manuscript Submitted
28 February 2024
With Journal Administrator
29 February 2024
With Editor
01 March 2024
Out for Review

93 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务